Etiology and Natural History of Neutropenia in Human Immunodeficiency Virus Disease: a Prospective Study
Overview
Authors
Affiliations
The objective of this prospective, observational study was to define the natural history of neutropenia in human immunodeficiency virus (HIV) disease. Eighty-seven consecutive patients developing neutropenia (absolute neutrophil count [ANC], <1000 cells/mm(3)) were recruited and closely followed for the duration of the episode. Episodes lasted a median of 13 days, with a mean ANC nadir of 660 cells/mm(3). Presumed or proven infection occurred in 12 (17%) of 71 evaluable subjects, and culture-proven infection occurred only in 6 (8%) of 71. Most of the episodes of neutropenia were brief, mild to moderate in nadir, and self-limiting without complications. Myelosuppressive therapies were implicated in almost all episodes. Serious infections occurred infrequently and were associated with low ANC nadirs but not with duration of the neutropenic episode. Low CD4(+) cell counts also increased the risk of infection complicating an episode of neutropenia.
Systemic and mucosal mobilization of granulocyte subsets during lentiviral infection.
Jones R, Manickam C, Ram D, Kroll K, Hueber B, Woolley G Immunology. 2021; 164(2):348-357.
PMID: 34037988 PMC: 8442246. DOI: 10.1111/imm.13376.
Ewing A, King C, Wiener J, Chasela C, Hudgens M, Kamwendo D AIDS. 2017; 31(18):2455-2463.
PMID: 28926409 PMC: 6059368. DOI: 10.1097/QAD.0000000000001641.
Leroi C, Balestre E, Messou E, Minga A, Sawadogo A, Drabo J PLoS One. 2017; 12(1):e0170753.
PMID: 28122041 PMC: 5266303. DOI: 10.1371/journal.pone.0170753.
Humphrey J, Walsh T, Gulick R Open Forum Infect Dis. 2016; 3(3):ofw135.
PMID: 27800523 PMC: 5084715. DOI: 10.1093/ofid/ofw135.
Neutropenia during HIV infection: adverse consequences and remedies.
Shi X, Sims M, Hanna M, Xie M, Gulick P, Zheng Y Int Rev Immunol. 2014; 33(6):511-36.
PMID: 24654626 PMC: 4873957. DOI: 10.3109/08830185.2014.893301.